Kaveh Hoda, MD
Internal Medicine · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hoda’s office at (925) 295-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A95531 · Current
Licensed to practise in California · since 2006 · expires 2028-04-30 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Drugs they prescribed that Part D paid
$31,403
Pharmacies billed $31,403 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 189) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
166 generic and 23 brand-name prescriptions · $31,403 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Sucralfate | 25 | $3,016 | $121 |
| Budesonide Dr | 11 | $1,300 | $118 |
| Pantoprazole | 53 | $585 | $11 |
| Gavilyte-C | 11 | $282 | $26 |
| Omeprazole | 12 | $120 | $10 |
Year by year
| 2024 | 189 | 78 | 0% (0) | 12% | $31,403 |
| 2023 | 315 | 161 | 0% (0) | 14% | $54,820 |
| 2022 | 461 | 300 | 0% (0) | 16% | $90,164 |
| 2021 | 459 | 274 | 0% (0) | 22% | $107,802 |
| 2020 | 293 | 187 | 0% (0) | 20% | $25,565 |
| 2019 | 379 | 263 | 0% (0) | 12% | $39,327 |
| 2018 | 353 | 254 | 0% (0) | 33% | $35,094 |
| 2017 | 357 | 258 | None | 9% | $41,668 |
| 2016 | 143 | 82 | 0% (0) | 22% | $132,230 |
| 2015 | 157 | 81 | 0% (0) | 20% | $111,888 |
| 2014 | 158 | 87 | 0% (0) | 23% | $118,890 |
| 2013 | 108 | 55 | 0% (0) | None | $40,755 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Sucralfate | 23 | $3,470 | $151 |
| Gavilyte-C | 101 | $2,050 | $20 |
| Pantoprazole | 79 | $932 | $12 |
2022: 5 drugs
| Humira | 13 | $57,799 | $4,446 |
| Sucralfate | 33 | $8,632 | $262 |
| Gavilyte-C | 187 | $3,242 | $17 |
| Pantoprazole | 113 | $2,262 | $20 |
| Peg-3350 and Electrolytes | 44 | $842 | $19 |
2021: 9 drugs
| Humira | 12 | $50,883 | $4,240 |
| Xifaxan | 13 | $32,336 | $2,487 |
| Sucralfate | 33 | $3,330 | $101 |
| Ursodiol | 12 | $2,311 | $193 |
| Peg-3350 and Electrolytes | 88 | $1,792 | $20 |
| Pantoprazole | 103 | $1,513 | $15 |
| Gavilyte-C | 94 | $1,423 | $15 |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C | 15 | $1,049 | $70 |
| Peg 3350-Electrolyte | 12 | $324 | $27 |
2020: 5 drugs
| Ursodiol | 16 | $2,604 | $163 |
| Sucralfate | 22 | $1,722 | $78 |
| Gavilyte-C | 71 | $1,399 | $20 |
| Pantoprazole | 78 | $1,208 | $15 |
| Peg-3350 and Electrolytes | 23 | $506 | $22 |
2019: 5 drugs
| Gavilyte-C | 172 | $6,089 | $35 |
| Ursodiol | 14 | $2,539 | $181 |
| Pantoprazole | 82 | $1,418 | $17 |
| Budesonide Ec | 11 | $1,268 | $115 |
| Sucralfate | 17 | $687 | $40 |
2018: 6 drugs
| Ursodiol | 27 | $3,755 | $139 |
| Gavilyte-C | 78 | $2,824 | $36 |
| Peg 3350-Electrolyte | 67 | $2,430 | $36 |
| Pantoprazole | 67 | $1,446 | $22 |
| Gavilyte-G | 22 | $510 | $23 |
| Peg 3350-Electrolyte | 11 | $293 | $27 |
2017: 3 drugs
| Lialda | 14 | $23,498 | $1,678 |
| Gavilyte-C | 213 | $3,621 | $17 |
| Pantoprazole | 40 | $1,020 | $25 |
2016: 4 drugs
| Lialda | 16 | $17,053 | $1,066 |
| Pantoprazole | 33 | $1,021 | $31 |
| Gavilyte-C | 41 | $697 | $17 |
| Omeprazole | 14 | $423 | $30 |
2015: 4 drugs
| Xifaxan | 12 | $20,977 | $1,748 |
| Pantoprazole | 48 | $1,579 | $33 |
| Gavilyte-C | 36 | $612 | $17 |
| Omeprazole | 16 | $545 | $34 |
2014: 3 drugs
| Pantoprazole | 46 | $1,164 | $25 |
| Omeprazole | 17 | $541 | $32 |
| Gavilyte-C | 29 | $493 | $17 |
2013: 3 drugs
| Moviprep | 25 | $1,449 | $58 |
| Omeprazole | 13 | $485 | $37 |
| Pantoprazole | 13 | $425 | $33 |
Professional record
- NPI
- 1720285273
- Licence
- CA A95531California A95531: Current · expires 2028-04-30
- Trained
- University of California, Davis School of Medicine, 2004
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 751 S Bascom Ave, Internal Med, San Jose, CA, 95128
- NPI first listed
- 2007-06-28
- NPI last updated
- 2024-02-22
- NPI record certified
- 2024-02-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 751 S Bascom Ave, San Jose, CA, 95128
This office lists an electronic records connection.